Pursuant to a sale purchase agreement entered into on 7 June 2018 between Mars
(as buyer) and Nordic Capital, Fidelio Capital and other minority shareholders of AniCura (as sellers), Mars will acquire 100% of the issued and to be issued share capital in AniCura.